Cannabis for Migraine and Headaches in Switzerland: What the Evidence Shows
A sober guide to cannabis, CBD and migraine: what the studies show, migraine vs tension and cluster headache, medication-overuse headache, interactions with triptans, and the Swiss route via neurology and prescription.
Migraine is not a niche problem in Switzerland: roughly one in eight people is affected, women about three times as often as men. Anyone with regular attacks knows the sequence — triptan, withdrawal, dark room, a lost day. It is no surprise that the question of whether cannabis or CBD helps eventually comes up. This guide sets out soberly what the research supports, where cannabis itself becomes a headache trigger, and which routes exist in Switzerland.
- • The evidence is mostly observational and app-based; controlled trials are few and small.
- • Inhalation acts fastest, which is why it dominates the research on acute attacks.
- • Daily use can drive a medication-overuse headache — the most underestimated risk.
- • Triptans, NSAIDs, beta blockers and CGRP antibodies should never be combined with cannabis unsupervised.
- • Migraine is not a standard indication for medical cannabis in Switzerland; the route runs through your GP and a neurologist.
Migraine, tension headache, cluster — why the difference matters
"Headache" covers three very different conditions. Migraine is a neurological disorder: pulsating, usually one-sided pain lasting 4 to 72 hours, worsened by movement, with nausea and sensitivity to light and sound, and in about a third of cases an aura. Tension-type headache is dull, bilateral, band-like, without nausea and without movement sensitivity. Cluster headache is an extremely severe, strictly one-sided pain around the eye in attacks of 15 to 180 minutes, often at night, with a watering eye and a blocked nose.
This is not academic. What helps a migraine attack does nothing for cluster headache, and what relieves tension headache — movement, fresh air — makes a migraine worse. If you do not know which type you have, you cannot make a sensible decision about cannabis either: the first step is a diagnosis, not a product.
What the research on cannabis and migraine shows
The honest summary: there are signals, but no proof. Three data sources carry most of the weight.
- App and registry data: Large analyses of symptom trackers show users reporting reduced pain intensity after inhaled use — often in around half of attacks. These datasets have no control group and no placebo arm, so the effect cannot be separated from expectation.
- Small controlled trials: Early cross-over studies with vaporised THC/CBD suggest more pain freedom at two hours than placebo. Sample sizes are small and follow-up short.
- Basic science: The endocannabinoid system is involved in pain processing in the trigeminal system. The "endocannabinoid deficiency" hypothesis in chronic migraine is plausible but unproven.
For prevention the picture is thinner still. Established prophylaxis — beta blockers, topiramate, amitriptyline, CGRP antibodies — has efficacy data; cannabis does not. Replacing a working preventive because one evening with cannabis felt better trades evidence for a feeling.
THC, CBD, CBN and terpenes — who does what?
THC changes pain perception and can suppress nausea; the antiemetic effect is the best-documented medical benefit of cannabis and matters when a migraine comes with vomiting. The cost is dose-dependent: racing heart, drop in blood pressure, anxiety — and excessive doses can worsen headache rather than relieve it.
CBD has no proven effect in migraine. It is well tolerated, not intoxicating, and may reduce tension and muscular tightness — plausible for a tension-type component, but too much to expect from it during a true migraine attack. How to dose systematically rather than by feel is covered in the CBD dosage guide; the difference between the cannabinoids is explained in CBD vs THC.
CBN is mostly associated with sedation — useful for sleeping after an attack, not during one. On terpenes: myrcene tends to sedate, limonene and pinene tend to feel clearer. There is no migraine-specific terpene evidence, but individual tolerance differs measurably — background in the guide to the entourage effect.
Expectation, evidence, risk — at a glance
| Expectation | What the evidence shows | Risk |
|---|---|---|
| "Vaporising stops my attack" | weak but real signals from small trials and app data | dosing errors, anxiety, circulatory reaction |
| "Cannabis replaces my triptan" | unproven, no head-to-head trials | untreated attacks, chronification |
| "CBD prevents attacks" | no efficacy data for prophylaxis | enzyme inhibition, interactions |
| "Daily works better than occasional" | the opposite is plausible: overuse headache | tolerance, rebound, more headache days |
| "It helps the nausea" | the best-documented THC effect there is | reversed in chronic use: CHS possible |
Medication-overuse headache: the biggest underestimated risk
Painkiller overuse is the classic path from episodic to chronic migraine. As a rule of thumb: simple analgesics on more than 15 days a month, triptans and combination products on more than 10 days — and the head hurts more often, not less.
Exact thresholds for cannabis are missing, but observations point the same way: daily users report more headache days, not fewer, and stopping brings a rebound phase with headache, irritability and disturbed sleep. That rebound is then misread as "so I do need it". How a planned break works is in the guide to tolerance and T-breaks; if the break fails, see cannabis withdrawal and dependence.
Interactions: triptans, NSAIDs, beta blockers, CGRP antibodies
- Triptans (sumatriptan, zolmitriptan): constrict vessels and increase cardiac load; THC raises heart rate on top. With pre-existing heart disease this is not a harmless mix.
- NSAIDs (ibuprofen, naproxen, aspirin): no known direct interaction, but the overuse trap adds up.
- Beta blockers (propranolol, metoprolol): THC can lower blood pressure and push the pulse — dizziness on standing becomes more likely.
- Amitriptyline: tricyclics and THC both raise heart rate, plus additive sedation.
- Topiramate, valproate: CBD can shift blood levels via liver enzymes — antiepileptics need monitoring.
- CGRP antibodies (erenumab, fremanezumab): not metabolised by liver enzymes, so direct interactions are unlikely — but your neurologist should still know what else you use.
The mechanism is explained in cannabis interactions with medication.
Method and dose: what actually fits
In an attack, speed matters. Vaporising acts within minutes and can be titrated step by step, which is why it is the format used in trials. One draw, wait five minutes, reassess: that avoids the overdose that itself causes headache and anxiety. Device questions are covered in the vaporizer guide, and the routes of administration in consumption methods compared.
Oils and tinctures take 30 to 90 minutes — too slow for an attack, useful for tense evenings and poor sleep. Edibles are the worst fit for attacks: up to two hours to onset, hard to control, and with nausea and vomiting oral absorption is unreliable anyway. Details in the guide to cannabis edibles.
A headache diary is the most important part of the experiment: date, attack severity, what you took, effect at two hours. After four to six weeks you have a pattern instead of a memory — and a neurologist can work with it.
When cannabis is the trigger
This is rarely mentioned but common. Four patterns:
- Withdrawal headache: 24 to 72 hours after the last use, typical in daily users — easily mistaken for migraine.
- Dehydration and blood pressure drop: after a high dose, often with dizziness — water and rest are the answer, not more cannabis.
- Smoking instead of vaporising: combustion products and carbon monoxide are headache triggers in their own right.
- Mixing with alcohol: the most reliable recipe for a bad next morning — see mixing cannabis and alcohol.
If an episode gets out of hand — panic, racing heart, circulation — follow the steps in first aid for too much cannabis. General adverse effects are summarised in cannabis side effects.
The Swiss route: neurology, prescription, insurance
Start with your GP: confirm the diagnosis, count headache days, discuss prophylaxis above four attacks a month, and refer to neurology when the picture is unclear. Medical cannabis has been available on a narcotics prescription in Switzerland since 2022, but migraine is not among the established indications — practice focuses on spasticity, chronic pain and chemotherapy-induced nausea. The process is explained in cannabis prescriptions in Switzerland, and cover in medical cannabis and health insurance.
Without a prescription, legal declared products stay in the CBD range below 1% THC — what is allowed and what is not is set out in buying cannabis in Switzerland. For chronic pain beyond the head, see cannabis for pain.
What this means for the club
We do not treat migraine and we do not claim to. What the club provides is traceability: lab-tested batches with declared THC and CBD values, documented terpene profiles and consistent cultivars — so that a self-experiment can actually be evaluated. If you do not know what was in it, you cannot know what worked. How to read a certificate of analysis is covered in reading a lab report.
CannabisClub.ch — declared values instead of guesswork
Lab-tested quality with documented cannabinoid and terpene profiles. Join for free — no obligation.
Frequently asked questions
- Does cannabis help with migraine?
- There are signals but no proof. App and registry data plus small trials with vaporised THC/CBD show a reported drop in pain intensity during acute attacks. Controlled studies are small and short, so cannabis is not an established migraine treatment.
- Is CBD effective for headaches?
- No migraine-specific effect has been demonstrated. CBD may reduce tension and muscular tightness, which can help a tension-type component. During an acute migraine attack, CBD alone should not be expected to abort the attack.
- Can cannabis itself cause headaches?
- Yes. Typical causes are withdrawal headache 24 to 72 hours after the last use in daily users, headache from dehydration and a drop in blood pressure after high doses, smoking instead of vaporising, and mixing with alcohol.
- Can I combine cannabis with triptans?
- Not without medical advice. Triptans constrict blood vessels and increase cardiac load, while THC raises heart rate. With existing cardiovascular disease this combination is particularly risky.
- What is medication-overuse headache?
- A headache caused by taking painkillers too often: simple analgesics on more than 15 days a month, triptans on more than 10 days. Daily cannabis use can likewise lead to more headache days and a rebound phase when stopping.
- Can I get medical cannabis for migraine in Switzerland?
- Usually not. Prescribing on a narcotics prescription has been possible since 2022, but migraine is not an established indication. Practice focuses on spasticity, chronic pain and chemotherapy-induced nausea.
- Which method fits an acute attack best?
- Vaporising, because it acts within minutes and can be titrated step by step. Oils take 30 to 90 minutes and edibles up to two hours — and with nausea and vomiting, oral absorption is unreliable anyway.